Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomes
伊沃西尼用于治疗IDH1突变型2-4级胶质瘤:耐受性、疗效预测因素和结果
期刊:NeuroOncology Advances
影响因子:4.1
doi:10.1093/noajnl/vdae227
Lanman, Tyler A; Youssef, Gilbert; Huang, Raymond; Rahman, Rifaquat; DeSalvo, Matthew; Flood, Thomas; Hassanzadeh, Elmira; Lang, Min; Lauer, Jason; Potter, Christopher; Jiao, Albert; Pan, Ian; Cahill, Daniel P; Lan, Zhou; Ospina, Juan Pablo; Nakhate, Vihang; Stec, Natalie E; Shi, Diana; Bi, Wenya Linda; McBrayer, Samuel K; Arrillaga-Romany, Isabel; Lee, Eudocia Q; Chukwueke, Ugonma N; Nayak, Lakshmi; Forst, Deborah A; Gerstner, Elizabeth R; Jordan, Justin T; Dietrich, Jorg; Miller, Julie; Batchelor, Tracy T; Reardon, David A; Wen, Patrick Y; Gonzalez Castro, L Nicolas